Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 3/2020

29.01.2019 | Cardiomyopathy

Dynamic unipolar voltage criteria of right ventricular septum for identifying left ventricular septal scar

verfasst von: Chin-Yu Lin, Fa-Po Chung, Yenn-Jiang Lin, Yun-Yu Chen, Shih-Lin Chang, Li-Wei Lo, Yu-Feng Hu, Jo-Nan Liao, Ta-Chuan Tuan, Tze-Fan Chao, Abigail Louise D. Te, Shinya Yamada, Ling Kuo, Jennifer Jeanne B. Vicera, Ting-Yung Chang, Simon Salim, Ting-Chung Huang, Chih-Min Liu, Cheng-I Wu, Shih-Ann Chen

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The right ventricular (RV) septal unipolar voltage (UV) for predicting left ventricular (LV) septal scar wall thickness (WT) remains to be elucidated.

Methods

From 2013 to 2015, data obtained from RV and LV electroanatomic maps of 28 patients (mean age, 53 ± 16 years; 19 men [67.9%]) with/without identified LV septal scars were reviewed. Patients with an RV septal scar were excluded (n = 90). Direct measurement of septal WT was conducted (mean distance, 10.4 ± 3.3 mm). Patients in group 1 had a normal LV substrate, while those in group 2 had an LV septal scar. Fisher’s linear discriminant formula was used to determine the dynamic UV criteria.

Results

A total of 552 points were collected: 323 in 12 patients from group 1 and 229 in 16 patients from group 2. The UV of the RV septum is capable of identifying the opposite LV endocardial bipolar scar and is proportional to the WT of the interventricular septum. In the absence of an RV endocardial scar, the formula of “RV septal cut-off value = 0.736 × WT − 0.117 mV” has better sensitivity and specificity for predicting the LV septal scar (0.96 vs. 0.68 and 0.91 vs. 0.80, respectively) than the predefined fixed criteria of 8.3 mV with a net reclassification improvement of 25.7% (P < 0.001).

Conclusions

The combined measurement of UV and WT is more sensitive than the predefined fixed UV criteria for defining deep scars.
Literatur
1.
Zurück zum Zitat Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108(6):704–10.CrossRef Hsia HH, Callans DJ, Marchlinski FE. Characterization of endocardial electrophysiological substrate in patients with nonischemic cardiomyopathy and monomorphic ventricular tachycardia. Circulation. 2003;108(6):704–10.CrossRef
2.
Zurück zum Zitat Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43(10):1834–42.CrossRef Soejima K, Stevenson WG, Sapp JL, Selwyn AP, Couper G, Epstein LM. Endocardial and epicardial radiofrequency ablation of ventricular tachycardia associated with dilated cardiomyopathy: the importance of low-voltage scars. J Am Coll Cardiol. 2004;43(10):1834–42.CrossRef
3.
Zurück zum Zitat Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101(11):1288–96.CrossRef Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation. 2000;101(11):1288–96.CrossRef
4.
Zurück zum Zitat Delacretaz E, Stevenson WG, Ellison KE, Maisel WH, Friedman PL. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol. 2000;11(1):11–7.CrossRef Delacretaz E, Stevenson WG, Ellison KE, Maisel WH, Friedman PL. Mapping and radiofrequency catheter ablation of the three types of sustained monomorphic ventricular tachycardia in nonischemic heart disease. J Cardiovasc Electrophysiol. 2000;11(1):11–7.CrossRef
5.
Zurück zum Zitat Aldhoon B, Frankel DS, Hutchinson MD, Callans DJ, Epstein AE, Dixit S, et al. Unipolar voltage abnormality is associated with greater left ventricular dysfunction in ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014;25(3):293–8.CrossRef Aldhoon B, Frankel DS, Hutchinson MD, Callans DJ, Epstein AE, Dixit S, et al. Unipolar voltage abnormality is associated with greater left ventricular dysfunction in ischemic cardiomyopathy. J Cardiovasc Electrophysiol. 2014;25(3):293–8.CrossRef
6.
Zurück zum Zitat Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Riley MP, Garcia FC, et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(1):49–55.CrossRef Hutchinson MD, Gerstenfeld EP, Desjardins B, Bala R, Riley MP, Garcia FC, et al. Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy. Circ Arrhythm Electrophysiol. 2011;4(1):49–55.CrossRef
7.
Zurück zum Zitat Polin GM, Haqqani H, Tzou W, Hutchinson MD, Garcia FC, Callans DJ, et al. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2011;8(1):76–83.CrossRef Polin GM, Haqqani H, Tzou W, Hutchinson MD, Garcia FC, Callans DJ, et al. Endocardial unipolar voltage mapping to identify epicardial substrate in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Heart Rhythm. 2011;8(1):76–83.CrossRef
8.
Zurück zum Zitat Chi PC, Lin YJ, Chang SL, Lo LW, Hu YF, Chao TF, et al. Unipolar peak-negative voltage as an endocardial electrographic characteristic to predict overlying abnormal epicardial substrates in patients with right epicardial ventricular tachycardia. J Cardiovasc Electrophysiol. 2014;25(12):1343–9.PubMed Chi PC, Lin YJ, Chang SL, Lo LW, Hu YF, Chao TF, et al. Unipolar peak-negative voltage as an endocardial electrographic characteristic to predict overlying abnormal epicardial substrates in patients with right epicardial ventricular tachycardia. J Cardiovasc Electrophysiol. 2014;25(12):1343–9.PubMed
9.
Zurück zum Zitat Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7(3):414–23.CrossRef Oloriz T, Silberbauer J, Maccabelli G, Mizuno H, Baratto F, Kirubakaran S, et al. Catheter ablation of ventricular arrhythmia in nonischemic cardiomyopathy: anteroseptal versus inferolateral scar sub-types. Circ Arrhythm Electrophysiol. 2014;7(3):414–23.CrossRef
10.
Zurück zum Zitat Haqqani HM, Tschabrunn CM, Tzou WS, Dixit S, Cooper JM, Riley MP, et al. Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. Heart Rhythm. 2011;8(8):1169–76.CrossRef Haqqani HM, Tschabrunn CM, Tzou WS, Dixit S, Cooper JM, Riley MP, et al. Isolated septal substrate for ventricular tachycardia in nonischemic dilated cardiomyopathy: incidence, characterization, and implications. Heart Rhythm. 2011;8(8):1169–76.CrossRef
11.
Zurück zum Zitat Lin CY, Chung FP, Lin YJ, Chen SA. Intramural reentrant ventricular tachycardia in a patient with severe hypertensive left ventricular hypertrophy. Korean Circ J. 2015;45(6):526–30.CrossRef Lin CY, Chung FP, Lin YJ, Chen SA. Intramural reentrant ventricular tachycardia in a patient with severe hypertensive left ventricular hypertrophy. Korean Circ J. 2015;45(6):526–30.CrossRef
12.
Zurück zum Zitat Santangeli P, Marchlinski FE. Substrate mapping for unstable ventricular tachycardia. Heart Rhythm. 2016;13(2):569–83.CrossRef Santangeli P, Marchlinski FE. Substrate mapping for unstable ventricular tachycardia. Heart Rhythm. 2016;13(2):569–83.CrossRef
13.
Zurück zum Zitat Betensky BP, Kapa S, Desjardins B, Garcia FC, Callans DJ, Dixit S, et al. Characterization of trans-septal activation during septal pacing: criteria for identification of intramural ventricular tachycardia substrate in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6(6):1123–30.CrossRef Betensky BP, Kapa S, Desjardins B, Garcia FC, Callans DJ, Dixit S, et al. Characterization of trans-septal activation during septal pacing: criteria for identification of intramural ventricular tachycardia substrate in nonischemic cardiomyopathy. Circ Arrhythm Electrophysiol. 2013;6(6):1123–30.CrossRef
14.
Zurück zum Zitat Lin CY, Silberbauer J, Lin YJ, Lo MT, Lin C, Chang HC, et al. Simultaneous amplitude frequency electrogram transformation (SAFE-T) mapping to identify ventricular tachycardia arrhythmogenic potentials in sinus rhythm. JACC Clin Electrophysiol. 2016;2(4):459–70.CrossRef Lin CY, Silberbauer J, Lin YJ, Lo MT, Lin C, Chang HC, et al. Simultaneous amplitude frequency electrogram transformation (SAFE-T) mapping to identify ventricular tachycardia arrhythmogenic potentials in sinus rhythm. JACC Clin Electrophysiol. 2016;2(4):459–70.CrossRef
15.
Zurück zum Zitat Zheng Y, Fernandes MR, Silva GV, Cardoso CO, Canales J, Gahramenpour A, et al. Histopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia. Exp Clin Cardiol. 2008;13(4):198–203.PubMedPubMedCentral Zheng Y, Fernandes MR, Silva GV, Cardoso CO, Canales J, Gahramenpour A, et al. Histopathological validation of electromechanical mapping in assessing myocardial viability in a porcine model of chronic ischemia. Exp Clin Cardiol. 2008;13(4):198–203.PubMedPubMedCentral
16.
Zurück zum Zitat Wolf T, Gepstein L, Dror U, Hayam G, Shofti R, Zaretzky A, et al. Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol. 2001;37(6):1590–7.CrossRef Wolf T, Gepstein L, Dror U, Hayam G, Shofti R, Zaretzky A, et al. Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction. J Am Coll Cardiol. 2001;37(6):1590–7.CrossRef
17.
Zurück zum Zitat Kornowski R, Hong MK, Gepstein L, Goldstein S, Ellahham S, Ben-Haim SA, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation. 1998;98(11):1116–24.CrossRef Kornowski R, Hong MK, Gepstein L, Goldstein S, Ellahham S, Ben-Haim SA, et al. Preliminary animal and clinical experiences using an electromechanical endocardial mapping procedure to distinguish infarcted from healthy myocardium. Circulation. 1998;98(11):1116–24.CrossRef
18.
Zurück zum Zitat Desjardins B, Crawford T, Good E, Oral H, Chugh A, Pelosi F, et al. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm. 2009;6(5):644–51.CrossRef Desjardins B, Crawford T, Good E, Oral H, Chugh A, Pelosi F, et al. Infarct architecture and characteristics on delayed enhanced magnetic resonance imaging and electroanatomic mapping in patients with postinfarction ventricular arrhythmia. Heart Rhythm. 2009;6(5):644–51.CrossRef
19.
Zurück zum Zitat Codreanu A, Odille F, Aliot E, Marie PY, Magnin-Poull I, Andronache M, et al. Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol. 2008;52(10):839–42.CrossRef Codreanu A, Odille F, Aliot E, Marie PY, Magnin-Poull I, Andronache M, et al. Electroanatomic characterization of post-infarct scars comparison with 3-dimensional myocardial scar reconstruction based on magnetic resonance imaging. J Am Coll Cardiol. 2008;52(10):839–42.CrossRef
20.
Zurück zum Zitat Kawamura Y, Page PL, Cardinal R, Savard P, Nadeau R. Mapping of septal ventricular tachycardia: clinical and experimental correlations. J Thorac Cardiovasc Surg. 1996;112(4):914–25.CrossRef Kawamura Y, Page PL, Cardinal R, Savard P, Nadeau R. Mapping of septal ventricular tachycardia: clinical and experimental correlations. J Thorac Cardiovasc Surg. 1996;112(4):914–25.CrossRef
21.
Zurück zum Zitat Cano O, Hutchinson M, Lin D, Garcia F, Zado E, Bala R, et al. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol. 2009;54(9):799–808.CrossRef Cano O, Hutchinson M, Lin D, Garcia F, Zado E, Bala R, et al. Electroanatomic substrate and ablation outcome for suspected epicardial ventricular tachycardia in left ventricular nonischemic cardiomyopathy. J Am Coll Cardiol. 2009;54(9):799–808.CrossRef
22.
Zurück zum Zitat Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977–85.CrossRef Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol. 2006;48(10):1977–85.CrossRef
Metadaten
Titel
Dynamic unipolar voltage criteria of right ventricular septum for identifying left ventricular septal scar
verfasst von
Chin-Yu Lin
Fa-Po Chung
Yenn-Jiang Lin
Yun-Yu Chen
Shih-Lin Chang
Li-Wei Lo
Yu-Feng Hu
Jo-Nan Liao
Ta-Chuan Tuan
Tze-Fan Chao
Abigail Louise D. Te
Shinya Yamada
Ling Kuo
Jennifer Jeanne B. Vicera
Ting-Yung Chang
Simon Salim
Ting-Chung Huang
Chih-Min Liu
Cheng-I Wu
Shih-Ann Chen
Publikationsdatum
29.01.2019
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 3/2020
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-019-00512-3

Weitere Artikel der Ausgabe 3/2020

Journal of Interventional Cardiac Electrophysiology 3/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.